JEL
LIVE

Serial Number

97576363

Owner

AiViva Biopharma, Inc.

Attorney

Joe McKinney Muncy

First Use Date

May 6, 2024

Filing Date

Sep 2, 2022

Add to watchlist:

No watchlists yet
View on USPTO

JEL Trademark

Serial Number: 97576363 • Registration: 8274375

JEL is a trademark filed by AiViva Biopharma, Inc. on September 2, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

AiViva Biopharma, Inc. (3 trademarks)

Suite 101
Dover, DE 19904

Entity Type: 03

Trademark Details

Filing Date

September 2, 2022

Registration Date

May 26, 2026

First Use Anywhere

May 6, 2024

First Use in Commerce

May 6, 2024

Published for Opposition

April 23, 2024

Goods & Services

Glaucoma agents; Irrigating solutions for eye use; Medicated eye washes; Eye drops; Ocular pharmaceuticals; Ophthalmic preparations; Ophthalmologic preparations; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical products for ophthalmological use; Dermatological pharmaceutical products; Medical preparations, namely, foot, hand and skin creams for diabetics; Medicated dermatological preparations and substances; Medicated skin preparation for use in treating wound healing; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Medicated ointments for treating dermatological conditions; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicated skin care preparations; Pharmaceutical preparation for skin care; Pharmaceutical preparations for skin care; Medicinal creams for skin care; Frostbite salve for pharmaceutical purposes; Poultices; Gelatine for medical purposes; wound-healing ointments for pharmaceutical purposes; Sunburn ointments; Acne treatment preparations; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of gel that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations for prostatic diseases and conditions; Pharmaceutical preparations for benign prostatic hyperplasia; Pharmaceutical preparations for the treatment and prevention of prostatic diseases and conditions; Pharmaceutical preparations for the treatment and prevention of benign prostatic hyperplasia

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 26, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 4, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 4, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 4, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 3, 2026 AITU
USE AMENDMENT FILED
Oct 8, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 8, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jun 5, 2025 EX2G
SOU EXTENSION 2 FILED
Jun 5, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 5, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 28, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jun 28, 2024 EX1G
SOU EXTENSION 1 FILED
Jun 28, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 28, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 18, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 23, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 23, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 3, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 13, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 6, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 6, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 11, 2023 GNFN
FINAL REFUSAL E-MAILED
Dec 11, 2023 GNFR
FINAL REFUSAL WRITTEN
Dec 11, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 4, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 4, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 4, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 6, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jul 6, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jul 6, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 20, 2023 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 11, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 11, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 11, 2023 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 21, 2022 NWOS
NEW APPLICATION ENTERED
Sep 6, 2022 NWAP